196 related articles for article (PubMed ID: 26473376)
1. Radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying anti-rheumatic drugs.
Nakajima A; Aoki Y; Sonobe M; Takahashi H; Saito M; Terayama K; Nakagawa K
Mod Rheumatol; 2016 Jul; 26(4):517-21. PubMed ID: 26473376
[TBL] [Abstract][Full Text] [Related]
2. Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritis.
Nakajima A; Aoki Y; Terayama K; Sonobe M; Takahashi H; Saito M; Nakagawa K
Mod Rheumatol; 2017 Nov; 27(6):967-972. PubMed ID: 28271947
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (bDMARDs): Results of 3 to 4 years of follow-up.
Nakajima A; Terayama K; Sonobe M; Aoki Y; Takahashi H; Akatsu Y; Taniguchi S; Yamada M; Kubota A; Nakagawa K
Mod Rheumatol; 2019 Nov; 29(6):903-909. PubMed ID: 30285585
[No Abstract] [Full Text] [Related]
4. Ultrasound disease activity of bilateral wrist and finger joints at three months reflects the clinical response at six months of patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.
Kawashiri SY; Nishino A; Shimizu T; Umeda M; Fukui S; Nakashima Y; Suzuki T; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Aoyagi K; Kawakami A
Mod Rheumatol; 2017 Mar; 27(2):252-256. PubMed ID: 27585858
[TBL] [Abstract][Full Text] [Related]
5. Radiographic changes and factors associated with subsequent progression of damage in weight-bearing joints of patients with rheumatoid arthritis under TNF-blocking therapies-three-year observational study.
Matsushita I; Motomura H; Seki E; Kimura T
Mod Rheumatol; 2017 Jul; 27(4):570-575. PubMed ID: 27589926
[TBL] [Abstract][Full Text] [Related]
6. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
7. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
[TBL] [Abstract][Full Text] [Related]
8. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs.
Mamehara A; Sugimoto T; Sugiyama D; Morinobu S; Tsuji G; Kawano S; Morinobu A; Kumagai S
Kobe J Med Sci; 2010 Sep; 56(3):E98-107. PubMed ID: 21063156
[TBL] [Abstract][Full Text] [Related]
9. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
[TBL] [Abstract][Full Text] [Related]
10. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
Bakker MF; Jacobs JW; Kruize AA; van der Veen MJ; van Booma-Frankfort C; Vreugdenhil SA; Bijlsma JW; Lafeber FP; Welsing PM
Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of understanding radiographic findings in relation to clinical outcomes in rheumatoid arthritis.
Keystone EC
J Rheumatol Suppl; 2009 Jun; 82():11-6. PubMed ID: 19509325
[TBL] [Abstract][Full Text] [Related]
12. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
13. A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.
Hashimoto J; Garnero P; van der Heijde D; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Yoshikawa H; Nishimoto N
Mod Rheumatol; 2009; 19(3):273-82. PubMed ID: 19452245
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis.
Motomura H; Matsushita I; Seki E; Mine H; Kimura T
Int J Rheum Dis; 2014 Sep; 17(7):749-54. PubMed ID: 24251619
[TBL] [Abstract][Full Text] [Related]
15. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
[TBL] [Abstract][Full Text] [Related]
16. Impact of early radiographic remission on the 15-year radiographic outcome in patients with rheumatoid arthritis.
Tiippana-Kinnunen T; Laasonen L; Kautiainen H; Paimela L; Leirisalo-Repo M
Scand J Rheumatol; 2011; 40(4):263-8. PubMed ID: 21417549
[TBL] [Abstract][Full Text] [Related]
17. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
Klarenbeek NB; Güler-Yüksel M; van der Heijde DM; Hulsmans HM; Kerstens PJ; Molenaar TH; de Sonnaville PB; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2010 Dec; 69(12):2107-13. PubMed ID: 20610442
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
[TBL] [Abstract][Full Text] [Related]
19. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
Yonemoto Y; Okamura K; Takeuchi K; Kaneko T; Kobayashi T; Okura C; Tsushima Y; Takagishi K
Rheumatol Int; 2016 Jan; 36(1):109-15. PubMed ID: 26232929
[TBL] [Abstract][Full Text] [Related]
20. Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis.
Henaux S; Ruyssen-Witrand A; Cantagrel A; Barnetche T; Fautrel B; Filippi N; Lukas C; Raffeiner B; Rossini M; Degboé Y; Constantin A
Ann Rheum Dis; 2018 Apr; 77(4):515-522. PubMed ID: 29187350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
